Ovagen

Last Updated: May 2026

Ovagen is a synthetic tripeptide (Glu-Asp-Leu) from the Khavinson bioregulator family, researched for hepatic-tissue-targeted bioregulation, liver function, and hepatocyte protein synthesis. Despite the name suggesting an ovarian target, the published Khavinson literature places Ovagen as a liver-targeted bioregulator. It is not approved by the FDA, EMA, or any major Western regulator and is sold as a research-use-only compound by third-party laboratories.

What is Ovagen and how does the hepatic bioregulatory mechanism work?

Ovagen is a synthetic Glu-Asp-Leu tripeptide proposed to enter hepatocyte nuclei and modulate gene expression in pathways related to hepatic protein synthesis, liver regeneration, and hepatocellular function. Within the Khavinson framework, Ovagen is the liver-targeted complement to organ-specific bioregulators like Cardiogen (cardiac) and Pancragen (pancreatic). Preclinical work has reported effects on hepatic protein synthesis markers and recovery parameters in liver injury models. Evidence level: Preclinical (rodent liver models); Khavinson-group research; independent replication limited.

What does the research show for Ovagen?

Preclinical rodent studies from the Khavinson group have reported effects on hepatic protein synthesis, recovery from chemical-induced liver injury, and gene expression markers in hepatocytes. Human clinical research at FDA-grade Phase 2/3 standards has not been conducted. Russian clinical use has been reported in hepatic-recovery and bioregulator-protocol contexts. Evidence level: Preclinical (rodent); Khavinson-group research; FDA-grade Phase 2/3 not conducted.

How does Ovagen compare to other Khavinson bioregulators?

Ovagen sits in the visceral-organ-targeting subset of the Khavinson cluster, alongside Pancragen (pancreatic), Prostamax (prostate), and Testagen (testicular).

What are the documented side effects of Ovagen?

Side effects in available preclinical data and community-reported research use are mild — injection-site reactions are the most common report. Long-term safety in humans at sustained research-use dosing is not characterized at Western clinical standards. Evidence level: Preclinical safety; human long-term unestablished.

What is the regulatory status of Ovagen?

Ovagen is not approved by the FDA, EMA, or any major Western regulator as of May 2026. Regulatory context in FDA peptide regulation 2025–2026 timeline.

Why does Ovagen vendor verification matter?

Ovagen's name is sometimes confusingly conflated with ovarian-targeting compounds despite its liver-targeted positioning in the published Khavinson literature. Identity verification via mass spectrometry confirms the Glu-Asp-Leu sequence. Independent HPLC purity testing is the standard quality signal. Guidance in how-to-test-peptides hub.

How does Peptigrity verify Ovagen vendors?

Peptigrity purchases Ovagen vials anonymously at standard customer pricing, sends them to ISO-accredited third-party labs for HPLC and mass spectrometry analysis, and publishes the unedited certificate of analysis. Methodology in how we calculate trust scores.

Frequently Asked Questions

What does Ovagen do?

Ovagen is proposed to act on hepatic (liver) tissue through epigenetic gene-expression modulation, with preclinical research focused on hepatocyte function and liver recovery markers. Human Phase 2/3 efficacy is not established at Western clinical standards.

Is Ovagen for the liver or ovaries?

Despite the name suggesting an ovarian target, the published Khavinson literature places Ovagen as a liver-targeted bioregulator. The naming convention in the Khavinson cluster sometimes reflects historical research-program designations rather than transparent organ targeting.

Is Ovagen legal to purchase?

Ovagen is legal to purchase as a research chemical for laboratory use in most jurisdictions, but it is not approved for human consumption in the US, EU, or most Western markets. Country breakdown in peptide legal status guide.

Will Ovagen be FDA-approved?

No active FDA approval pathway exists for Ovagen as of May 2026.

How can I verify an Ovagen vendor is selling real product?

Independent third-party HPLC certificate of analysis from a lab the vendor does not own or pay, with mass spectrometry identity confirmation. COA interpretation in red flags in peptide certificates of analysis.

Does Peptigrity recommend an Ovagen dose?

No. Ovagen is not approved for human consumption in Western jurisdictions and Peptigrity is an independent review platform, not a medical authority. Anyone considering use should consult a licensed physician.

This section is for educational and informational purposes only and does not constitute medical advice. Ovagen is not approved by the FDA or any major Western regulator for human use. Always consult a qualified healthcare provider before using any peptide or research compound. Peptigrity is an independent review platform and does not sell, endorse, or recommend specific products or vendors.